Source: International Congress 2018 – Clinical trials in COPD: new results
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Kostikas (Basel, Switzerland), A. Mackay (London, United Kingdom), C. Vogelmeier (Marburg, Germany), S. Frent (Timisoara, Romania), P. Pfister (Basel, Switzerland), P. Gupta (Hyderabad, India), D. Banerji (East Hanover, United States of America), F. Patalano (Basel, Switzerland), J. Wedzicha (London, United Kingdom). Early Clinically Important Improvement (ECII) and exacerbation outcomes in the FLAME study. 1657

Member's Comments

No comment yet.

Related content which might interest you: Preliminary outcomes of the CREWS study Source: International Congress 2015 – Best abstracts in chronic care Year: 2015 Late Breaking Abstract - Early benefits in patient-reported outcomes (PROs) and physical activity (PA) in patients with severe eosinophilic asthma (SEA) treated with benralizumab: interim analysis of the imPROve Asthma study Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Disease awareness in COPD: Analyses of clinical parameters and patient-reported outcome from the SAT study Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 Patient-reported outcomes as predictors of COPD exacerbations - a prospective study Source: International Congress 2014 – COPD markers Year: 2014 Accuracy of the Adaptive Computerized COPD Exacerbation Self-management Support (ACCESS) application to support patients’ exacerbation self-management. Preliminary results Source: International Congress 2017 – Innovation in pulmonary rehabilitation and chronic care Year: 2017 Metrics of salbutamol use as predictors of future adverse outcomes in asthma Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013 Clinical trials for elderly patients with multiple diseases (CHROMED): A pilot study Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Gender differences in patients with severe asthma in real-life setting: data from the Severe Asthma Network in Italy (SANI) registry Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Factors influencing to HRQOL of patients with mild to moderate persistent asthma in Japan; sub-analysis of GAIA study Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Reduction in clinically important deterioration in COPD with aclidinium/formoterol Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Late Breaking Abstract - Lung ultrasound for severity assessment and outcome prediction of COVID-19 patients. Source: Virtual Congress 2020 – Transthoracic and endobronchial ultrasound Year: 2020 LATE-BREAKING ABSTRACT: Early identification of responders to reslizumab at 16 weeks using an algorithm derived from the pivotal clinical studies of severe eosinophilic asthma (SEA) patients Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016 Respiratory effectiveness group study: Predictors of frequent severe asthma exacerbations Source: International Congress 2015 – Management of asthma and COPD in primary care Year: 2015 Correlation between meteo-climatological factors and asthma exacerbation among children: A prospective study Source: International Congress 2016 – Living with asthma around the globe Year: 2016 LATE-BREAKING ABSTRACT: Benralizumab provides significant improvements for patients with severe, uncontrolled asthma: SIROCCO Phase III results Source: International Congress 2016 – Novel strategies on COPD and asthma management Year: 2016 X-Tab: Non-interventional study to assess patient-related mid-term outcomes of omalizumab therapy in severe allergic asthmatic patients Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Detection of asthma patient-reported exacerbations during follow-up in the ASTROLAB cohort Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Main and additional predictors of COPD progression Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 A service evaluation of the accuracy of the Gold Standard Framework Proactive Indicator Guidance (GSF PIG)  in predicting 12 month mortality in patietns with a diagnosis of Chronic Obstructive Pulmonary Disease (COPD). Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Identifying patients at risk for future exacerbations of asthma: Development of a prediction model Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015